微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 6.97% | -12.11% | 122.68% | 40/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 3.13% | -16.98% | 81.98% | 54/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 1.72% | -22.52% | -76.73% | 61/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 7.39% | 10.3% | -6.81% | 37/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 7.93% | -4.23% | 110.34% | 35/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 3.77% | -12.93% | 69.82% | 51/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.22% | -22.65% | -66.87% | 49/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 6.7% | 7.03% | -19.08% | 49/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 8.28% | 7.39% | 91.22% | 38/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.33% | 8.52% | 50.87% | 46/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.87% | 16.67% | -54.15% | 38/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 6.26% | -10.57% | -18.81% | 52/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 7.71% | -7.78% | 93.23% | 42/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.99% | -11.53% | 62.2% | 52/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.46% | 6.03% | -64.86% | 49/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 7% | 11.64% | -16.27% | 57/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 8.36% | -2.56% | 85.37% | 41/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.51% | 15.35% | 94.4% | 51/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.32% | 13.73% | -63% | 51/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 6.27% | -33.72% | -26.92% | 67/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 8.58% | -38.41% | 119.44% | 46/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.91% | -55.06% | 91.67% | 68/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.04% | 2% | -78.44% | 63/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 9.46% | -33.33% | -32.09% | 57/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 13.93% | 10.03% | 60.11% | 20/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 8.7% | -5.95% | -38.69% | 27/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 14.19% | -15.44% | -15.44% | 33/159 | 2.62% | 汇宇制药 | 31.9% | 行业排名> |
| 2018-12-31 | 16.78% | 39.02% | 39.02% | 26/159 | 7.16% | 誉衡药业 | 35.56% | 行业排名> |
| 2017-12-31 | 12.07% | -19.69% | -19.69% | 37/159 | 9.61% | 奥赛康 | 35% | 行业排名> |
| 2016-12-31 | 15.03% | -7.85% | 62.49% | 35/159 | 6.11% | 奥赛康 | 28.15% | 行业排名> |
| 2016-06-30 | 9.25% | 2% | -43.29% | 17/159 | 3.56% | 宏源药业 | 21.91% | 行业排名> |